Threshold Pharma (THLD) – Major News
-
Threshold Pharma (THLD) to Merge with Molecular Templates
-
Threshold Pharma (THLD) to Discontinue Tarloxotinib Development; Will Refocus Resources
-
Threshold Pharma (THLD) Says Two Studies Didn't Meet Activity Thresholds, Plans Workforce Reduction
-
Threshold Pharma (THLD) Reports Q2 Loss of $0.10/Share
-
Threshold Pharma (THLD) Tops Q3 EPS by 5c
-
Threshold Pharma (THLD) Posts Q4 Loss of 12c/Share
-
Threshold Pharma (THLD) Misses Q3 EPS by 3c
-
Threshold Pharmaceuticals (THLD) Misses Q4 EPS by 3c
-
Threshold Pharmaceuticals (THLD) Posts Q3 Op. Profit of 2c/Share
-
Threshold Pharmaceuticals (THLD) Posts Q1 Loss of 16c/Share
-
Threshold (THLD) Higher as P-3 Moves Forward, Earns $30M Milestone Payment
-
Threshold Pharmaceuticals (THLD) Reports In-Line Q3 Loss of 6c/Share
-
Threshold Pharmaceuticals (THLD) Widens Q1 Loss to $2.12/Share
-
Threshold Pharmaceuticals (THLD) Reports Q3 Loss of 8c/Share
-
Threshold Pharma (THLD) Posts Narrower-than-Expected Q4 Loss
Back to THLD Stock Lookup